A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer

BACKGROUND: Advanced relapsed ovarian cancer has a poor prognosis, and treatment options are limited. METHODS: This phase I trial investigated the dosage, safety, pharmacokinetics and efficacy of trabectedin plus pegylated liposomal doxorubicin (PLD) in Japanese patients with advanced relapsed ovari...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Shunji, Takekuma, Munetaka, Tamura, Kenji, Takehara, Kazuhiro, Nomura, Hiroyuki, Ono, Makiko, Yunokawa, Mayu, Aoki, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449774/
https://www.ncbi.nlm.nih.gov/pubmed/34189636
http://dx.doi.org/10.1007/s10147-021-01973-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449774/
https://www.ncbi.nlm.nih.gov/pubmed/34189636
http://dx.doi.org/10.1007/s10147-021-01973-1

Ejemplares similares